1-5 of 5
Adel K. El-Naggar
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Akt/mTOR Counteract the Antitumor Activities of Cixutumumab, an Anti-Insulin–like Growth Factor I Receptor Monoclonal Antibody

Dong Hoon Shin, Hye-Young Min, Adel K. El-Naggar, Scott M. Lippman, Bonnie Glisson, Ho-Young Lee
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (12): 2437–2448.
https://doi.org/10.1158/1535-7163.MCT-11-0235
Published: 07 December 2011
View article titled, Akt/mTOR Counteract the Antitumor Activities of Cixutumumab, an Anti-Insulin–like Growth Factor I Receptor Monoclonal Antibody
Open the PDF for Akt/mTOR Counteract the Antitumor Activities of Cixutumumab, an Anti-Insulin–like Growth Factor I Receptor Monoclonal Antibody in another window
Includes: Supplementary data
Journal Articles

Serum Signature of Hypoxia-Regulated Factors Is Associated with Progression after Induction Therapy in Head and Neck Squamous Cell Cancer

Lauren Averett Byers, F. Christopher Holsinger, Merrill S. Kies, William N. William, Adel K. El-Naggar, J. Jack Lee, Jianhua Hu, Adriana Lopez, Hai T. Tran, Shaoyu Yan, Zhiqiang Du, K. Kian Ang, Bonnie S. Glisson, Maria Gabriela Raso, Ignacio I. Wistuba, Jeffrey N. Myers, Waun-Ki Hong, Vali Papadimitrakopoulou, Scott M. Lippman, John V. Heymach
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2010) 9 (6): 1755–1763.
https://doi.org/10.1158/1535-7163.MCT-09-1047
Published: 09 June 2010
View article titled, Serum Signature of Hypoxia-Regulated Factors Is Associated with Progression after Induction Therapy in Head and Neck Squamous Cell Cancer
Open the PDF for Serum Signature of Hypoxia-Regulated Factors Is Associated with Progression after Induction Therapy in Head and Neck Squamous Cell Cancer in another window
Journal Articles

Medullary thyroid cancer: targeting the RET kinase pathway with sorafenib/tipifarnib

David Hong, Lei Ye, Robert Gagel, Lakshmi Chintala, Adel K. El Naggar, John Wright, Razelle Kurzrock
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2008) 7 (5): 1001–1006.
https://doi.org/10.1158/1535-7163.MCT-07-2422
Published: 15 May 2008
View article titled, Medullary thyroid cancer: targeting the RET kinase pathway with sorafenib/tipifarnib
Open the PDF for Medullary thyroid cancer: targeting the RET kinase pathway with sorafenib/tipifarnib in another window
Journal Articles

Sorafenib inhibits the angiogenesis and growth of orthotopic anaplastic thyroid carcinoma xenografts in nude mice

Seungwon Kim, Yasemin D. Yazici, Gabriel Calzada, Zhuo-Ying Wang, Maher N. Younes, Samar A. Jasser, Adel K. El-Naggar, Jeffrey N. Myers
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (6): 1785–1792.
https://doi.org/10.1158/1535-7163.MCT-06-0595
Published: 15 June 2007
View article titled, Sorafenib inhibits the angiogenesis and growth of orthotopic anaplastic thyroid carcinoma xenografts in nude mice
Open the PDF for Sorafenib inhibits the angiogenesis and growth of orthotopic anaplastic thyroid carcinoma xenografts in nude mice in another window
Journal Articles

Concomitant inhibition of epidermal growth factor and vascular endothelial growth factor receptor tyrosine kinases reduces growth and metastasis of human salivary adenoid cystic carcinoma in an orthotopic nude mouse model

Maher N. Younes, Young Wook Park, Yasemin Dakak Yazici, Meirong Gu, Alfredo A. Santillan, Xiaolin Nong, Seungwon Kim, Samar A. Jasser, Adel K. El-Naggar, Jeffrey N. Myers
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2006) 5 (11): 2696–2705.
https://doi.org/10.1158/1535-7163.MCT-05-0228
Published: 22 November 2006
View article titled, Concomitant inhibition of epidermal growth factor and vascular endothelial growth factor receptor tyrosine kinases reduces growth and metastasis of human salivary adenoid cystic carcinoma in an orthotopic nude mouse model
Open the PDF for Concomitant inhibition of epidermal growth factor and vascular endothelial growth factor receptor tyrosine kinases reduces growth and metastasis of human salivary adenoid cystic carcinoma in an orthotopic nude mouse model in another window